Subbiah, V., Mansfield, A. S., Taylor, M. H., Schuler, M., Hadoux, J., Curigliano, G., Wirth, L. J., Alonso, G., Adkins, D., Lopes, G., Ahn, M., Lin, C., Brose, M. S., Garralda, E., Bowles, D. W., Baik, C. S., Sheppard, A. D., Wang, S., Gainor, J. F. (2026). Efficacy and safety of pralsetinib in advanced or metastatic RET -altered thyroid cancer (TC): Final analysis of the phase 1/2 ARROW study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6028